Walmart stock rises even as the retailer says the range of outcomes for first-quarter operating income growth had widened ...

This was the stock's fourth consecutive day of losses.

By Jonathan Stempel NEW YORK (Reuters) -Bristol Myers Squibb won the dismissal of a proposed class action accusing it of ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has been named ...

Find out how Bristol Myers Squibb was honored for 50 years of service in Lawrence, from local support to global medical ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Sell rating on Bristol-Myers Squibb (BMY – Research Report), with a ...

Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent ...

Shares of Bristol Myers Squibb Co. BMY shed 3.32% to $55.30 Friday, on what proved to be an all-around grim trading session ...

Shares in major U.S. and European pharmaceutical companies fell sharply Wednesday, underperforming a broader market downturn, after U.S. President Donald Trump said the country would soon impose “a ...

Equities research analysts at Zacks Research dropped their Q1 2027 earnings per share (EPS) estimates for shares of ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...